 Cysteine Proteinase Inhibitors
"Cysteine Proteinase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.
| Descriptor ID |
D015853
|
| MeSH Number(s) |
D27.505.519.389.745.325
|
| Concept/Terms |
Cysteine Proteinase Inhibitors- Cysteine Proteinase Inhibitors
- Inhibitors, Cysteine Proteinase
- Proteinase Inhibitors, Cysteine
- Cysteine Protease Inhibitors
- Inhibitors, Cysteine Protease
- Protease Inhibitors, Cysteine
- Cysteine Proteinase Antagonists
- Antagonists, Cysteine Proteinase
- Proteinase Antagonists, Cysteine
alpha-Cysteine Protease Inhibitors- alpha-Cysteine Protease Inhibitors
- Inhibitors, alpha-Cysteine Protease
- Protease Inhibitors, alpha-Cysteine
- alpha Cysteine Protease Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Cysteine Proteinase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cysteine Proteinase Inhibitors".
This graph shows the total number of publications written about "Cysteine Proteinase Inhibitors" by people in this website by year, and whether "Cysteine Proteinase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2006 | 2 | 1 | 3 | | 2014 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cysteine Proteinase Inhibitors" by people in Profiles.
-
Contaldo C, Myers TJ, Zucchini C, Manara MC, Chiodoni C, Colombo MP, Nicoletti G, Lollini PL, Li T, Longobardi L, Scotlandi K, Spagnoli A. Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. Growth Factors. 2014 Feb; 32(1):41-52.
-
Zhang L, Nie L, Maki CG. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity. Mol Cancer. 2006 Dec 06; 5:68.
-
Bové J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu DC, Kordower JH, Petrucelli L, Przedborski S. Proteasome inhibition and Parkinson's disease modeling. Ann Neurol. 2006 Aug; 60(2):260-4.
-
Kordower JH, Kanaan NM, Chu Y, Suresh Babu R, Stansell J, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol. 2006 Aug; 60(2):264-8.
-
Dodel RC, Du Y, Bales KR, Ling Z, Carvey PM, Paul SM. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res Mol Brain Res. 1999 Jan 22; 64(1):141-8.
-
Dodel RC, Du Y, Bales KR, Ling ZD, Carvey PM, Paul SM. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 1998 Oct; 86(3):701-7.
-
Mundle SD, Venugopal P, Cartlidge JD, Pandav DV, Broady-Robinson L, Gezer S, Robin EL, Rifkin SR, Klein M, Alston DE, Hernandez BM, Rosi D, Alvi S, Shetty VT, Gregory SA, Raza A. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996 Oct 01; 88(7):2640-7.
-
Maki CG, Huibregtse JM, Howley PM. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 1996 Jun 01; 56(11):2649-54.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|